Literature DB >> 12637131

Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly.

Harvey Jay Cohen1, Tamara Harris, Carl F Pieper.   

Abstract

PURPOSE: This study was performed to determine the effects of markers of inflammation (interleukin 6) and coagulation (D-dimer) on mortality and functional status in older persons.
METHODS: Subjects were selected for the Duke Established Populations for Epidemiologic Studies of the Elderly. In 1992, 2569 subjects (age >71 years) were interviewed, of whom 1,723 had interleukin-6 and D-dimer measurements. Values of interleukin 6 and D-dimer were categorized into quartiles. Outcomes were mortality (through 5 years) and functional status (through 4 years). Relative risks were estimated with proportional hazards models that adjusted for potential confounders.
RESULTS: The relative risk of mortality was 1.28 (95% confidence interval [CI]: 0.98 to 1.69; P = 0.06) for those with only interleukin-6 levels in the highest quartile, 1.53 (95% CI: 1.18 to 1.97; P = 0.001) for subjects with only D-dimer levels in the highest quartile, and 2.00 (95% CI: 1.53 to 2.62; P = 0.0001) for those with levels of both in the highest quartile, as compared with those who were not in either of the highest quartiles. Those with high interleukin-6 and high D-dimer levels had the greatest declines in all measures of function.
CONCLUSION: Activation of the coagulation and inflammatory pathways is associated with mortality and decline in function, and may be part of the explanation for the development of a frailty phenotype in the elderly.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12637131     DOI: 10.1016/s0002-9343(02)01484-5

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  101 in total

1.  Inflammation and mortality in a frail mouse model.

Authors:  Fred Ko; Qilu Yu; Qian-Li Xue; Wenliang Yao; Cory Brayton; Huanle Yang; Neal Fedarko; Jeremy Walston
Journal:  Age (Dordr)       Date:  2011-06-02

Review 2.  Adjuvant chemotherapy for breast cancer in older women: emerging evidence to aid in decision making.

Authors:  Gretchen Kimmick
Journal:  Curr Treat Options Oncol       Date:  2011-09

3.  Proteomic screening of glycoproteins in human plasma for frailty biomarkers.

Authors:  Kinza S Shamsi; Anson Pierce; Aaron S Ashton; Dipti G Halade; Arlan Richardson; Sara E Espinoza
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-01-04       Impact factor: 6.053

4.  Senior adult oncology.

Authors:  Arti Hurria; Ilene S Browner; Harvey Jay Cohen; Crystal S Denlinger; Mollie deShazo; Martine Extermann; Apar Kishor P Ganti; Jimmie C Holland; Holly M Holmes; Mohana B Karlekar; Nancy L Keating; June McKoy; Bruno C Medeiros; Ewa Mrozek; Tracey O'Connor; Stephen H Petersdorf; Hope S Rugo; Rebecca A Silliman; William P Tew; Louise C Walter; Alva B Weir; Tanya Wildes
Journal:  J Natl Compr Canc Netw       Date:  2012-02       Impact factor: 11.908

5.  Effects of Aging on Inflammation and Hemostasis through the Continuum of Critical Illness.

Authors:  Sachin S Kale; Sachin Yende
Journal:  Aging Dis       Date:  2011-12-02       Impact factor: 6.745

6.  Muscle strength is associated with adipose tissue gene expression of inflammatory adipokines in postmenopausal women.

Authors:  Xuewen Wang; Tongjian You; Rongze Yang; Mary F Lyles; Jamehl Demons; Da-Wei Gong; Barbara J Nicklas
Journal:  Age Ageing       Date:  2010-03-15       Impact factor: 10.668

Review 7.  Soluble biomarkers and morbidity and mortality among people infected with HIV: summary of published reports from 1997 to 2010.

Authors:  James D Neaton; Jacqueline Neuhaus; Sean Emery
Journal:  Curr Opin HIV AIDS       Date:  2010-11       Impact factor: 4.283

8.  Change in frailty and risk of death in older persons.

Authors:  A S Buchman; R S Wilson; J L Bienias; D A Bennett
Journal:  Exp Aging Res       Date:  2009 Jan-Mar       Impact factor: 1.645

9.  Effect of statin therapy in reducing the risk of serious non-AIDS-defining events and nonaccidental death.

Authors:  E T Overton; D Kitch; C A Benson; P W Hunt; J H Stein; M Smurzynski; H J Ribaudo; P Tebas
Journal:  Clin Infect Dis       Date:  2013-02-05       Impact factor: 9.079

10.  Prospective associations between inflammatory and hemostatic markers and physical functioning limitations in mid-life women: Longitudinal results of the Study of Women's Health Across the Nation (SWAN).

Authors:  Candace K McClure; Samar R El Khoudary; Carrie A Karvonen-Gutierrez; Kelly R Ylitalo; Kristin Tomey; Trang VoPham; Barbara Sternfeld; Jane A Cauley; Siobán Harlow
Journal:  Exp Gerontol       Date:  2013-11-07       Impact factor: 4.032

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.